[go: up one dir, main page]

NO20064240L - Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav - Google Patents

Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav

Info

Publication number
NO20064240L
NO20064240L NO20064240A NO20064240A NO20064240L NO 20064240 L NO20064240 L NO 20064240L NO 20064240 A NO20064240 A NO 20064240A NO 20064240 A NO20064240 A NO 20064240A NO 20064240 L NO20064240 L NO 20064240L
Authority
NO
Norway
Prior art keywords
processes
preparation
oral administration
pharmaceutical compounds
composition
Prior art date
Application number
NO20064240A
Other languages
English (en)
Norwegian (no)
Inventor
Claudia Mattern
Original Assignee
Mattern Udo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mattern Udo filed Critical Mattern Udo
Publication of NO20064240L publication Critical patent/NO20064240L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO20064240A 2004-02-20 2006-09-19 Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav NO20064240L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003906A EP1566173B1 (fr) 2004-02-20 2004-02-20 Composition pharmaceutique orale et procédé de preparation
PCT/EP2005/001297 WO2005079759A2 (fr) 2004-02-20 2005-02-09 Composition pharmaceutique pour administration per os et mode de fabrication

Publications (1)

Publication Number Publication Date
NO20064240L true NO20064240L (no) 2006-11-20

Family

ID=34707350

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064240A NO20064240L (no) 2004-02-20 2006-09-19 Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav

Country Status (16)

Country Link
US (1) US7767228B2 (fr)
EP (2) EP1566173B1 (fr)
JP (1) JP4800225B2 (fr)
AT (1) ATE336230T1 (fr)
AU (1) AU2005215108B2 (fr)
BR (1) BRPI0507848A (fr)
CA (1) CA2554640C (fr)
DE (1) DE602004001969T2 (fr)
DK (1) DK1566173T3 (fr)
ES (1) ES2271714T3 (fr)
NO (1) NO20064240L (fr)
PT (1) PT1566173E (fr)
RU (1) RU2342936C2 (fr)
SI (1) SI1566173T1 (fr)
WO (1) WO2005079759A2 (fr)
ZA (1) ZA200606554B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106000B2 (en) * 2005-05-18 2012-01-31 Da Volterra Colonic delivery of adsorbents
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
JP5860284B2 (ja) * 2008-12-05 2016-02-16 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 針状の活性物質を含む押出物
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
RU2514056C2 (ru) * 2012-08-21 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
JP6472341B2 (ja) * 2015-06-26 2019-02-20 株式会社トーヨー技術研究所 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法
CA3191671A1 (fr) 2020-09-04 2022-03-10 Elanco Us Inc. Formulations palatables
CN117881425A (zh) * 2021-08-31 2024-04-12 株式会社东洋技术研究所 水栖动物用经口给药药剂
CN117915955A (zh) * 2021-08-31 2024-04-19 株式会社东洋技术研究所 水栖动物用经口给药药剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1879601A (en) * 1926-03-13 1932-09-27 Merck & Co Inc Iodine composition
NL294490A (fr) * 1962-06-25
US3709833A (en) * 1970-08-21 1973-01-09 Owens Illinois Inc Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
SU1465052A1 (ru) * 1985-06-10 1989-03-15 Институт Зоологии Ан Казсср Способ профилактики и лечени гельминтозов животных
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
RU2034549C1 (ru) * 1990-05-29 1995-05-10 Научно-производственное малое предприятие "Аксис" Антгельминтное средство для лечения нематодозов овец
JPH05238930A (ja) * 1992-02-28 1993-09-17 Eisai Co Ltd 持続性薬剤
RU2092155C1 (ru) * 1993-06-22 1997-10-10 Валентина Ивановна Ходак Способ получения твердого лекарственного препарата для перорального введения
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5827497A (en) * 1996-08-14 1998-10-27 Mayo Foundation For Medical Education And Research Charcoal-radionuclide agents for measurement of gastrointestinal transit
CN1158071C (zh) * 1997-05-30 2004-07-21 渗透有限公司 多层渗透装置
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
EP1362583A1 (fr) * 2002-05-15 2003-11-19 CUM Taste Masking AG Procédé pour masquer le goût de substances par microencapsulation
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
JP4603357B2 (ja) * 2002-08-13 2010-12-22 インターベツト・インターナシヨナル・ベー・ベー 添加剤をデリバリーするための組成物及び方法
WO2004040679A1 (fr) * 2002-10-31 2004-05-13 Matsushita Electric Industrial Co., Ltd. Electrode poreuse et dispositif electrochimique reposant sur l'utilisation de ladite electrode

Also Published As

Publication number Publication date
RU2342936C2 (ru) 2009-01-10
US7767228B2 (en) 2010-08-03
EP1715850A2 (fr) 2006-11-02
DK1566173T3 (da) 2006-12-27
CA2554640A1 (fr) 2005-09-01
WO2005079759A2 (fr) 2005-09-01
AU2005215108A1 (en) 2005-09-01
WO2005079759A3 (fr) 2006-06-15
BRPI0507848A (pt) 2007-07-10
ATE336230T1 (de) 2006-09-15
US20050186272A1 (en) 2005-08-25
DE602004001969T2 (de) 2007-03-15
JP2007523108A (ja) 2007-08-16
SI1566173T1 (sl) 2006-12-31
CA2554640C (fr) 2011-04-12
EP1566173A1 (fr) 2005-08-24
AU2005215108B2 (en) 2010-10-07
JP4800225B2 (ja) 2011-10-26
RU2006133543A (ru) 2008-04-10
EP1566173B1 (fr) 2006-08-16
PT1566173E (pt) 2006-12-29
DE602004001969D1 (de) 2006-09-28
ES2271714T3 (es) 2007-04-16
ZA200606554B (en) 2008-05-28

Similar Documents

Publication Publication Date Title
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
NO20090328L (no) Nye forbindelser 385
NO20043367L (no) Oralt farmasoytisk preparat
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
EE200300329A (et) Meetod peroraalselt manustatavate epotiloonide biosaadavuse suurendamiseks ning selles kasutatav komplekt, ravimkoostis ja farmatseutiline ravimvorm
EE200300373A (et) Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20081844L (no) Terapeutiske forbindelser
WO2005075425A3 (fr) Derives de bisaryluree
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
NO20090327L (no) Nye forbindelser 384
NO20064240L (no) Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
ATE556074T1 (de) Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
SE0401655D0 (sv) New compounds
MXPA05009686A (es) Composicion farmaceutica comprendiendo acido 5-metil-2-(2'-cloro-6'-fluoroanilino) fenilacetico.
TW200800984A (en) New compounds
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
ECSP066564A (es) Formulaciones de tableta de liberación extendida de venlafaxina
EA200801634A1 (ru) Твердая фармацевтическая композиция, содержащая ирбесартан
CY1110814T1 (el) Νεα υποκατεστημενα αρυλοεξαδιενικα οξεα και εστερες αυτων τα οποια μπορουν να χρησιμοποιηθουν για την αγωγη και προληψη του διαβητη, δυσλιπιδαιμιας και αθηροσκληρωσης, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και διεργασιες για την παρασκευη αυτων
ZA200706705B (en) Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
ATE517612T1 (de) Rabeprazol-formulierung
ATE301455T1 (de) Pharmazeutische zubereitung enthaltend valaciclovir

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application